Krystal Biotech Inc (KRYS)
156.66
-3.14
(-1.96%)
USD |
NASDAQ |
Dec 31, 16:00
156.73
+0.07
(+0.04%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Quarterly): 13.51M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 270.93M |
| Amicus Therapeutics Inc | 26.16M |
| Insmed Inc | 150.81M |
| Rhythm Pharmaceuticals Inc | 37.93M |
| Apellis Pharmaceuticals Inc | 88.57M |